Stoneweg Europe Stapled Trust
SGX:SET
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Stoneweg Europe Stapled Trust
SGX:SET
|
SG |
|
Cumberland Pharmaceuticals Inc
NASDAQ:CPIX
|
US |
|
Airports of Thailand PCL
SET:AOT
|
TH |
|
P
|
Palram Industries 1990 Ltd
TASE:PLRM
|
IL |
|
illimity Bank SpA
MIL:ILTY
|
IT |
|
P
|
Property Perfect PCL
SET:PF
|
TH |
|
BioNexus Gene Lab Corp
NASDAQ:BGLC
|
MY |
|
I
|
Imperial Logistics Ltd
F:IUC1
|
ZA |
|
Bionomics Ltd
ASX:BNO
|
AU |
|
M
|
MDX PCL
SET:MDX
|
TH |
|
Methanex Corp
TSX:MX
|
CA |
Wall Street
Price Targets
SET Price Targets Summary
Stoneweg Europe Stapled Trust
According to Wall Street analysts, the average 1-year price target for
SET
is 1.96 EUR
with a low forecast of 1.9 EUR and a high forecast of 2.05 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is SET's stock price target?
Price Target
1.96
EUR
According to Wall Street analysts, the average 1-year price target for
SET
is 1.96 EUR
with a low forecast of 1.9 EUR and a high forecast of 2.05 EUR.
What is Stoneweg Europe Stapled Trust's Revenue forecast?
Projected CAGR
2%
For the last 6 years the
compound annual growth rate for
Stoneweg Europe Stapled Trust's revenue is
3%.
The projected
CAGR
for the next 3 years is
2%.
What is Stoneweg Europe Stapled Trust's Operating Income forecast?
Projected CAGR
2%
For the last 6 years the
compound annual growth rate for
Stoneweg Europe Stapled Trust's operating income is
3%.
The projected
CAGR
for the next 3 years is
2%.
What is Stoneweg Europe Stapled Trust's Net Income forecast?
Projected CAGR
0%
For the last 6 years the
compound annual growth rate for
Stoneweg Europe Stapled Trust's net income is
-6%.
The projected
CAGR
for the next 3 years is
0%.
